Insulin resistance (IR) and systemic hypertension are independently associated with heart failure. We reported previously that nitric oxide synthase 3 (NOS3) has a beneficial effect on left ventricular (LV) remodeling and function after pressure-overload in mice. The aim of our study was to investigate the interaction of IR and NOS3 in pressure-overloadinduced LV remodeling and dysfunction. Wild-type (WT) and NOS3-deficient (NOS3 Ϫ/Ϫ ) mice were fed either a standard diet (SD) or a high-fat diet (HFD) to induce IR. After 9 days of diet, mice underwent transverse aortic constriction (TAC). LV structure and function were assessed serially using echocardiography. Cardiomyocytes were isolated, and levels of oxidative stress were evaluated using 2=,7=-dichlorodihydrofluorescein diacetate. Cardiac mitochondria were isolated, and mitochondrial respiration and ATP production were measured. TAC induced LV remodeling and dysfunction in all mice. The TAC-induced decrease in LV function was greater in SD-fed NOS3 Ϫ/Ϫ mice than in SD-fed WT mice. In contrast, HFD-fed NOS3 Ϫ/Ϫ developed less LV remodeling and dysfunction and had better survival than did HFD-fed WT mice. Seven days after TAC, oxidative stress levels were lower in cardiomyocytes from HFD-fed NOS3 Ϫ/Ϫ than in those from HFD-fed WT. N -nitro-L-arginine methyl ester and mitochondrial inhibitors (rotenone and 2-thenoyltrifluoroacetone) decreased oxidative stress levels in cardiomyocytes from HFD-fed WT mice. Mitochondrial respiration was altered in NOS3 Ϫ/Ϫ mice but did not worsen after HFD and TAC. In contrast with its protective role in SD, NOS3 increases LV adverse remodeling after pressure overload in HFD-fed, insulin resistant mice. Interactions between NOS3 and mitochondria may be responsible for increased oxidative stress levels in HFD-fed WT mice hearts. oxidative stress; cardiac dysfunction INSULIN RESISTANCE (IR), a state defined as a decrease in the sensitivity of insulin-mediated glucose disposal, is frequently present in obese subjects (11). It is estimated that over 35 million Americans are insulin resistant (34). IR is a risk factor for congestive heart failure, independently of established risk factors including diabetes (19). Moreover, IR commonly clusters with other cardiovascular risk factors such as hypertension, a chronic state of pressure-overload that can lead to heart failure (20). We previously developed a mouse model of combined IR and pressure-overload, by feeding mice a high-fat diet (HFD) followed by transverse aortic constriction (TAC) (30). In mice, the presence of IR induced by HFD is associated with an adverse left ventricular (LV) remodeling response to chronic pressure-overload. This adverse remodeling response can be detected 7 days after pressure-overload (30).
INSULIN RESISTANCE (IR), a state defined as a decrease in the sensitivity of insulin-mediated glucose disposal, is frequently present in obese subjects (11) . It is estimated that over 35 million Americans are insulin resistant (34) . IR is a risk factor for congestive heart failure, independently of established risk factors including diabetes (19) . Moreover, IR commonly clusters with other cardiovascular risk factors such as hypertension, a chronic state of pressure-overload that can lead to heart failure (20) . We previously developed a mouse model of combined IR and pressure-overload, by feeding mice a high-fat diet (HFD) followed by transverse aortic constriction (TAC) (30) . In mice, the presence of IR induced by HFD is associated with an adverse left ventricular (LV) remodeling response to chronic pressure-overload. This adverse remodeling response can be detected 7 days after pressure-overload (30) .
Nitric oxide (NO), a free radical gas that is produced from the conversion of L-arginine to L-citrulline by three NO synthases (NOS) isoforms, has a variety of cardiovascular effects that modulate LV remodeling and function (12) . The presence of endothelial NOS (NOS3), a NOS isoform constitutively expressed both in vascular endothelial cells and cardiomyocytes, decreases LV remodeling and partially preserves LV function in a mouse model of chronic pressure-overload (3, 17, 33) . Both obesity and IR are associated with altered levels and activity of NOS3 (13, 15) , and the NOS3-deficient (NOS3 Ϫ/Ϫ ) mice have been reported to be insulin resistant (6, 8) , underlining the importance of the NO signaling pathways in these conditions. However, the role of NOS3 in LV remodeling after pressure overload in IR is unknown. Obesity and diabetes are accompanied by increased systemic oxidative stress (2) . It is conceivable that the effect of NOS3 on pressure-overloadinduced ventricular remodeling and failure differs in conditions of IR and insulin sensitivity. Indeed, in an environment of increased oxidative stress, the presence of NOS3 may lead to increased LV remodeling and dysfunction (39) .
Several mechanisms have been implicated in the deleterious interactions of NOS3 and oxidative stress. First, reactive oxygen species (ROS) can interact with NO to produce peroxynitrite. Second, the presence of increased oxidative stress may also promote a situation in which NOS3 produces superoxide rather than NO, a state known as NOS3 uncoupling (12) . Recently, Sud et al. (38) also reported that uncoupled NOS3 directly increased mitochondrial ROS production by increasing mitochondrial nitration, another possible mechanism by which NOS3 may augment ROS production during the uncoupled state. The increased oxidative and nitrosative stress induced by NOS3, in turn, can induce heart failure through cellular and mitochondrial damage (28, 41) .
The overall objective of the present study was to gain insights into the role of NOS3 on the modulation of LV remodeling and dysfunction in HFD-induced IR. Using the mouse model of IR and pressure-overload described previously, we report that after HFD feeding, NOS3 predisposes mice to adverse LV remodeling and dysfunction and increased cardiac oxidative stress levels. Interactions between NOS3 and mitochondria are involved in the cardiac increase in oxidative stress levels.
METHODS
Protocol. All animal procedures were conducted in C57BL6 male mice, in accordance with guidelines published in the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-23, Revised 1996), and were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care.
The model of IR and pressure-overload has been described previously (30) . Diets were started at 7 wk of age. In brief, wild-type (WT) and NOS3
Ϫ/Ϫ mice were fed a standard diet (SD; D12450B; Research Diets, New Brunswick, NJ) or a HFD (D12492; Research Diets) for 9 days, at which time TAC was performed (31) . The mice were kept on their respective diets for the remainder of the experiment. SD-fed and HFD-fed WT and NOS3 Ϫ/Ϫ mice were followed for 7 days after TAC, at which time they underwent an echocardiogram. In all other studies, we considered the procedure HFD feeding ϩ TAC as one intervention, mimicking the cluster of IR and pressure-overload. Thus we compared WT and NOS3
Ϫ/Ϫ mice that had been fed a SD without TAC (control mice) with mice that had been fed a HFD and had undergone TAC. The HFD-fed mice that had undergone TAC were studied 7 days after TAC except for a separate echocardiographic study in which echocardiograms were performed serially at 7 and 28 days after TAC.
Insulin tolerance and glucose tolerance tests were performed in WT and NOS3
Ϫ/Ϫ mice fed a SD or a HFD for a period of 9 -12 days (see
Metabolic tests).
Metabolic tests. At 10 -14 wk of age, WT and NOS3 Ϫ/Ϫ mice fed a SD or HFD for 9 days underwent an insulin tolerance test. A glucose tolerance test was obtained 3 days later. Insulin (6 h of fasting, 0.3 units/kg, Humulin-R; Elli Lilly) or glucose (16 h fasting, 0.5 g/kg of 5% dextrose; Hospira) was administered intraperitoneally. Blood samples were drawn from the tail vein, and glucose blood levels were measured at 0, 15, 30, 60, and 120 min using a BREEZE2 Blood Glucose Meter (Bayer).
Echocardiography. Echocardiography was performed using a 13-MHz linear-array transducer with a digital ultrasound system (Vivid 7; GE Medical Systems, Milwaukee, WI). The mice were lightly sedated using an intraperitoneal injection of ketamine (50 mg/kg). LV dimensions, mass, and shortening fraction were obtained from M mode tracings (17, 26) . Strain rate images were obtained from the parasternal short-axis views at the midventricular level (35) .
Isolation of cardiomyocytes. Cardiomyocytes were isolated using the method described by Lim et al. (24) . In brief, mice were euthanized with pentobarbital sodium, and the heart was harvested in a Ca 2ϩ -free Tyrode solution containing taurine (5 mM) and 2,3-butanedione monoxime (10 mM; buffer A). The heart was subsequently mounted on a Langendorff perfusion apparatus and perfused at 37°C with buffer A containing (in mg/ml) 0.5 collagenase B, 0.5 collagenase D (Roche Diagnostics, Rotkreuz, Switzerland), and 0.1 type XIV protease (Sigma-Aldrich, St. Louis, MO). The heart was perfused until the perfusion pressure decreased to ϳ30 mmHg. The LV was then isolated, minced in buffer A containing 5 g/l BSA at room temperature, and gently triturated 8 -10 times. The cell suspension was filtered through 300 m nylon mesh and kept at 37°C in Ca 2ϩ -free Tyrode solution and used within 2 to 4 h. Detection of oxidative stress levels in isolated cardiomyocytes. Cardiomyocytes were incubated with 2=,7=-dichlorodihydrofluorescein diacetate (DCF-DA; 2 mol/l; Invitrogen, Eugene, OR) for 30 min at 37°C in the dark (39) , and the fluorescent signal of DCF-DA was measured (Nikon Eclipse 80i; MVI, Avon, MA). Preincubation (20 min at 37°C) of cardiomyocytes with H 2O2 (20 mmol/l) or Tirone (10 mmol/l) before exposure to DCF-DA were used as positive and negative controls. The contribution of NOS to oxidative stress was evaluated by preincubating cardiomyocytes with the NOS inhibitor N -nitro-L-arginine methyl ester (L-NAME; 1 mmol/l) for 20 min at 37°C. The role of mitochondria in the production of ROS was assessed by preincubating cardiomyocytes for 20 min at 37°C with rotenone (10 mol/l), an inhibitor of complex I of the mitochondria electron chain, or 2-thenoyltrifluoroacetone, a complex II inhibitor (TTFA; 20 mol/l).
Measurement of NO production from cardiomyocytes. Cardiomyocytes were preincubated for 30 min at 37°C with L-NAME (100 mol) as a negative control, spermine NONOate (200 mol) as a positive control, TTFA (20 M), or rotenone (10 M). Cardiomyocytes were then loaded with diaminofluorescein diacetate (DAF-2DA; 10 M; Calbiochem, San Diego, CA) and incubated for 30 min at 37°C. The resulting fluorescence from the reaction between DAF-2DA and NO was quantified on a microplate reader (excitation 490 nm/ emission 510 nm; SpectraMax M5; Molecular Devices, Sunnyvale, CA) in triplicate for each compound.
Mitochondria isolation. Cardiac mitochondria were isolated using a modification of the procedure of Palmer et al. (29, 37) . In brief, the LV was placed into a buffer containing 100 mM KCl, 50 mM MOPS, 1 mM EGTA, 5 mM MgSO4, 1 mM ATP, and 2 mg/ml defatted BSA, pH 7.4, at 4°C and homogenized using a glass grinder. The mitochondria were collected after centrifugation at 3,000 g for 10 min at 4°C. The mitochondrial pellet was then washed twice with buffer containing 100 mM KCl, 50 mM MOPS, and 0.5 mM EGTA. Protein concentrations were obtained using bicinchoninic acid assay (Pierce, Rockford, IL). Mitochondria were kept on ice and used within 4 to 6 h.
Mitochondrial hydrogen peroxide production. The rate of hydrogen peroxide (H2O2) production in isolated mitochondria (0.2 mg of mitochondrial protein/ml) was monitored at 37°C for 30 min using the oxidation of the Amplex Red (33 M; Invitrogen) in the presence of horseradish peroxidase (HRP; 0.2 unit/ml) (27) . H 2O2 production was initiated in mitochondria using pyruvate (5 mM) and malate (5 mM) as substrates. Fluorescence was recorded on a microplate reader (545 nm excitation/590 nm emission; SpectraMax M5; Molecular Devices). Standard curves were obtained by adding known amounts of H2O2 to assay medium in the presence of the reactants (Amplex red and HRP). Results are reported as picomoles H 2O2 per minute per milligram mitochondrial protein.
Mitochondrial respiration. Oxygen consumption in freshly isolated mitochondria was measured at 37°C using a Clark-type oxygen electrode (Hansatech Oxygraph, Amesbury, MA) (21, 23) . Mitochondria (0.5 mg/ml) were incubated in a respiration buffer (pH 7.4) containing 130 mM KCl, 20 mM MOPS, 2.5 mM EGTA, 5 mM K2HPO4, 1 M Na4P2O7, and 0.1% BSA. Pyruvate (5 mM) and malate (5 mM) or palmitoyl carnitine (10 M) and malate (5 mM) were added as substrates, and state II oxygen consumption was then recorded for 60 s. State III was initiated by adding ADP (250 M). The respiratory control ratio (RCR; or ratio of state III to state IV) was calculated.
Mitochondrial ATP production rate. Mitochondrial ATP production rate was determined with a luminescence-based assay using the ATP Determination Kit (Invitrogen), as described previously (7, 25) . The reaction solution was made according to the manufacturer's instruction, except for replacement of dH 2O by the respiration buffer described previously. Substrates (5 mM pyruvate, 5 mM malate, or 10 M palmitoyl carnitine and 5 mM malate) were added to the reaction solution. Aliquots of mitochondria were diluted to a final concentration of 2 g mitochondrial protein/ml. ADP (250 M) was added to initiate oxidative phosphorylation. Luminescence was monitored for 5 min at room temperature using a SpectraMax M5 microplate reader. The standard curve was generated using known concentrations of ATP and was used to calculate the rate of ATP production. The ratio of ATP production per milliliter O2 used per minute during stage III was calculated as an index of mitochondrial efficiency.
Measurement of gene expression. RNA was extracted from the left ventricles of WT and NOS3
Ϫ/Ϫ mice fed a SD (no TAC) and of HFD-fed WT and NOS3 Ϫ/Ϫ mice 7 days after TAC using TRIzol reagent (Invitrogen, La Jolla, CA). cDNA was synthesized with Moloney murine leukemia virus reverse transcriptase (Invitrogen). Levels of mRNAs encoding NADPH oxidase 1, NADPH oxidase 2, and xanthine oxidase and 18S ribosomal RNA (rRNA) were measured by real-time PCR with a Mastercycler ep realplex 2 (Eppendorf, Westbury, NY) and their primers. Changes in gene expression normalized to levels of 18S rRNA were determined with the relative threshold cycle method (Applied Biosystems).
Immunoblot analysis. LV tissue samples of nonfasted WT mice fed a SD and HFD-fed WT mice 7 days after TAC were homogenized in 1 ml radioimmunoprecipitation assay buffer (Boston BioProducts) supplemented with 1% protease inhibitor cocktail and 1% phosphatase inhibitor cocktail (Sigma) and were microcentrifuged for 20 min at 20,000 g. Supernatant proteins (15 g) were fractionated on 10% SDS-PAGE gels and transferred to polyvinylidene difluoride membranes. Membranes were blocked for 1 h in 5% nonfat milk and incubated overnight with primary rabbit antibodies against NOS3 and Ser 1177 -NOS3 (diluted 1:1,000; Cell Signaling). Immunoblotting with a rabbit GAPDH antibody (Cell Signaling) was performed to confirm equal loading. Bound antibody was detected with HRP-labeled secondary antibody (Cell Signaling) in Tris-buffered saline-Tween milk and visualized via chemiluminescence with ECL Plus (Amersham Biosciences).
Statistical analysis. Statistical analysis was done with the JMP statistical package (SAS Institute, Cary, NC). Data are expressed as means Ϯ standard deviation. For comparison of metabolic and echocardiographic parameters over time, results were analyzed with an ANOVA for repeated measurements. If the interaction of time, diet, and genotype (for the 7 days follow-up) or time and genotype (for the 28 days follow-up) was significant, unpaired Student's t-tests were used to compare echocardiographic parameters between groups at the same time point. Analysis of survival rates after banding was performed with the log-rank test. Student's paired t-test was used for comparison of oxidative stress measurements between WT and NOS3 Ϫ/Ϫ , and ANOVA for repeated measurements were used to compare the effect of inhibitors on oxidative stress measurements in WT animals. A two-way ANOVA (effects of genotype and intervention) was used for comparison of mitochondrial parameters between mice. A probability value of Ͻ0.05 was considered significant.
RESULTS

Metabolic tests in SD-fed and HFD-fed WT and NOS3
Ϫ/Ϫ mice. NOS3 Ϫ/Ϫ mice fed a SD had an impaired tolerance to glucose but no impairment to insulin tolerance. In contrast, NOS3 Ϫ/Ϫ mice fed a HFD for 9 -12 days developed impaired tolerance both to glucose and insulin compared with HFD-fed WT mice (Fig. 1) .
LV remodeling and function after TAC in SD-fed and HFDfed WT and NOS3
Ϫ/Ϫ mice. Before TAC, echocardiographic parameters of LV size and function did not differ between SDand HFD-fed WT and NOS3
Ϫ/Ϫ mice (data not shown). Seven days after TAC, LV function assessed by fractional shortening (FS) decreased in all mice. Confirming our previous findings (17), SD-fed NOS3 Ϫ/Ϫ mice and HFD-fed WT mice decreased their FS more than SD-fed WT mice. The amount FS decreased was 34 Ϯ 5% in SD-fed NOS3 Ϫ/Ϫ mice (n ϭ 13) and 32 Ϯ 4% in HFD-fed WT mice (n ϭ 19) compared with 18 Ϯ 4% in SD-fed mice (n ϭ 18; P Ͻ 0.05 for both comparisons). In contrast, the decrease in FS was less in HFD-fed NOS3 Ϫ/Ϫ mice (11 Ϯ 4%; n ϭ 14) than in HFD-fed WT mice (P Ͻ 0.05).
Echocardiograms performed 28 days after TAC revealed that HFD-fed NOS3
Ϫ/Ϫ mice developed slightly less LV hypertrophy than HFD-fed WT mice with smaller posterior wall thickness and LV mass (Table 1) . This decreased LV remodeling was associated with a better LV function as demonstrated by a higher systolic strain rate and a trend toward a higher FS (P ϭ 0.09; Table 1 and Fig. 2 ) in the NOS3 Ϫ/Ϫ mice compared with the WT mice. LV mass and LV mass/body weight measured at necropsy (28 days after TAC, not shown in a table) were lower in HFD-fed NOS3 Ϫ/Ϫ mice than in HFD-fed WT mice (4.2 Ϯ 0.1 vs. 5.0 Ϯ 0.2 mg/g, respectively; P Ͻ 0.05). These findings suggest that in contrast with its protective role in SD-fed mice, NOS3 tends to increase LV adverse remodeling in HFD-fed mice.
Survival after TAC in HFD-fed WT and NOS3 Ϫ/Ϫ mice. Survival after TAC was greater in HFD-fed NOS3 Ϫ/Ϫ mice than in HFD-fed WT mice (100% vs. 50%; P Ͻ 0.05; Fig. 3 ) 28 days after TAC.
Oxidative stress levels in isolated cardiomyocytes in HFDfed WT and NOS3 Ϫ/Ϫ mice before and after TAC. Before TAC, there was no difference in oxidative stress measured by DCF-DA between cardiomyocytes from NOS3 Ϫ/Ϫ and WT mice fed a SD or a HFD (data not shown for SD; Fig. 4, A and  B, for HFD) . Seven days after TAC, oxidative stress levels in the cardiomyocytes of HFD-fed WT mice increased 12-fold compared with that of HFD-fed mice before TAC (P Ͻ 0.01; Fig. 4, A and B) . In contrast, oxidative stress levels in cardiomyocytes isolated from HFD-fed NOS3 Ϫ/Ϫ mice 7 days after TAC were not different from that measured in HFD-fed NOS3 Ϫ/Ϫ mice before TAC. Oxidative stress in cardiomyocytes isolated from HFD-fed NOS3
Ϫ/Ϫ mice 7 days after TAC was lower than that measured in cardiomyocytes isolated from WT (Fig. 4B) . The NOS inhibitor, L-NAME, decreased the oxidative stress level in cardiomyocytes isolated from HFD-fed WT mice 7 days after TAC, whereas it did not modify oxidative stress in cardiomyocytes isolated from NOS3 Ϫ/Ϫ mice (Fig. 4C ). Rotenone and TTFA, which, respectively, inhibit complex I and II of the mitochondrial electron chain, both markedly decreased oxidative stress level in cardiomyocytes isolated from HFD-fed WT animals 7 days after TAC (Fig.   4D ). Neither rotenone nor TTFA decreased NO production assessed by measuring DAF-2DA fluorescence in isolated cardiomyocytes of WT mice. These findings suggest that both the mitochondria and NOS3 are involved in the increased oxidative stress levels seen after HFD and TAC.
Mitochondrial hydrogen peroxide production in HFD-fed WT and NOS3
Ϫ/Ϫ mice after TAC. Seven days after TAC, there was no difference in hydrogen peroxide production from mitochondria isolated from HFD-fed NOS3 Ϫ/Ϫ mice and HFDfed WT mice (44 Ϯ 11 vs. 53 Ϯ 10 pmol·min Ϫ1 ·mg Ϫ1 ; P ϭ 0.2). These findings suggest that mitochondrial ROS production is not directly responsible for the increased oxidative stress levels seen after HFD and TAC.
Mitochondrial respiration and ATP production in WT and NOS3
Ϫ/Ϫ mice before and after HFD and TAC. LV mitochondria were isolated from SD-fed WT and NOS3 Ϫ/Ϫ mice. ATP production and the ratio of ATP production to oxygen con- sumption (reflecting mitochondrial efficiency) were less in the mitochondria of SD-fed NOS3 Ϫ/Ϫ mice than in SD-fed WT mice. The decrease in ATP production and mitochondrial efficiency was present both when pyruvate or palmitoylcarnitine was given as substrates (Tables 2 and 3) . Furthermore, when palmitoylcarnitine was given as a substrate, the ADPinduced maximal oxygen consumption (state III) was less in mitochondria from SD-fed NOS3 Ϫ/Ϫ mice than SD-fed WT mice ( Table 3) .
The effects of HFD and TAC on the mitochondria of WT and NOS3 Ϫ/Ϫ mice were then analyzed. The RCR (ratio of state III to state IV), which provides an index of mitochondrial respiration/phosphorylation coupling, was slightly less in mitochondria of HFD-fed WT mice 7 days after TAC than in mitochondria of SD-fed WT mice. This decrease was present both when pyruvate or palmitoyl-carnitine were given as substrates (Tables 2 and 3 ). In contrast with WT mice, HFD and TAC did not significantly affect oxygen consumption, the RCR, or the ratio of ATP production to oxygen consumption in the mitochondria of NOS3 Ϫ/Ϫ mice. Taken together, these results suggest that NOS3 Ϫ/Ϫ mice have decreased mitochondrial efficiency compared with WT mice when fed a SD; however, they may be less susceptible to changes in mitochondrial coupling after HFD feeding and TAC than WT mice. 
Phosphorylation of Ser
1177 -NOS3. Phosphorylation of Ser 1177 -NOS3 was increased in HFD-fed WT mice after TAC compared with control WT mice fed a SD (Fig. 5) , suggesting that activation of the phosphatidylinositol 3-kinase (PI3K)/ AKT pathway is present after HFD feeding and TAC.
Gene expression of other oxidative enzymes. There were no significant differences in the expression of NADPH oxidases 1 and 2 or of xanthine oxidase in the LV of WT and NOS3 Ϫ/Ϫ mice fed a SD diet (no TAC) and HFD-fed WT and NOS3 Ϫ/Ϫ mice 7 days after TAC (Fig. 6) .
DISCUSSION
This study demonstrates that NOS3 increases LV adverse remodeling and decreases LV systolic function in HFD-fed mice after pressure-overload. The increased LV remodeling in the presence of NOS3 was accompanied by a lower survival after pressure-overload in HFD-fed WT mice compared with HFD-fed NOS3 Ϫ/Ϫ mice. This deleterious role of NOS3 in HFD-fed mice contrasts with the protective role of NOS3 on LV function and remodeling in SD-fed mice after pressureoverload. HFD and TAC are associated with an increased level of oxidative stress in WT mice but not in NOS3 Ϫ/Ϫ mice. It is noteworthy that the HFD-fed NOS3 Ϫ/Ϫ mice, which appear to be partially protected from oxidative stress and LV remodeling/dysfunction after pressure-overload, also have marked metabolic abnormalities, with increased IR and glucose intolerance compared with HFD-fed WT mice. This discrepancy suggests that the oxidative stress observed in WT mice is due more to the presence of NOS3 than to other oxidative pathways increased in IR and obesity. When compared with WT mice, NOS3
Ϫ/Ϫ mice exhibit decreased mitochondrial respiration and ATP production before HFD feeding and TAC. Whereas WT mice develop mitochondrial uncoupling after HFD and TAC, no significant changes are noted in NOS3 Ϫ/Ϫ mice. We report a dual role of NOS3 in pressure-overload. The presence of NOS3 limits ventricular remodeling and dysfunction after TAC in mice fed a SD (10% fat) but modestly increases adverse remodeling in mice fed a HFD for 9 days before TAC. We have reported previously that a similar duration and composition of HFD induces IR in WT mice (30) . Hence, whereas NOS3 limits adverse ventricular remodeling in insulin-sensitive mice, the presence of NOS3 in insulin-resistant mice increases adverse ventricular remodeling. A dual role of NOS3 has also been reported in hepatic IR: overexpression of NOS3 limited hepatic injury in WT mice but increased hepatic injury in diabetic (dB/ Ϫ/Ϫ mice fed a SD (no TAC) and 7 days after TAC in HFD-fed mice. SD-WT SD-fed WT mice, HFD-WT HFD-fed WT mice 7 days after TAC, SD-NOS3, SD-fed NOS3 Ϫ/Ϫ mice, HFD-NOS3 HFD-fed NOS3
Ϫ/Ϫ mice 7 days after TAC. NOX1, NOX2, and XO mRNA levels are expressed as fold change vs. expression levels in SD-WT mice; n ϭ 5-7 mice in each group. dB) mice (9) . The present study demonstrates a similar dual role of NOS3 in cardiac pressure-overload.
Myocardial function was evaluated both by the LV FS and the LV maximal systolic radial strain rate. Both parameters demonstrated that NOS3 deficiency limited LV dysfunction after TAC in insulin-resistant mice. LV FS and strain rate were decreased in HFD-fed NOS3 Ϫ/Ϫ mice 7 days after TAC compared with SD-fed and HFD-fed NOS3 Ϫ/Ϫ mice before TAC. However, both the LV FS and strain rate were higher in HFD-fed NOS3 Ϫ/Ϫ mice than in HFD-fed WT 7 days after TAC. Strain rate is a sensitive parameter of mouse LV function (35) and was able to detect a difference in LV function between the surviving WT and NOS3 Ϫ/Ϫ mice 28 days after TAC. Strain rate is also a relatively load-independent measurement of LV function (14) . The decrease in strain rate observed in HFD-fed mice after TAC suggests a direct effect of HFD feeding and TAC on myocardial contractility.
The decreased LV function and increased LV remodeling seen in the HFD-fed WT mice after TAC was associated with a greater mortality than was observed in HFD-fed NOS3 Ϫ/Ϫ mice after TAC. Both heart failure and cardiac arrhythmias have been attributed to increased oxidative stress (1, 10, 28, 41, 42) and could be involved in the increased mortality observed in HFD-fed mice after TAC.
The protective role of NOS3 in ventricular remodeling and function in SD-fed mice confirms what we and others have observed (3, 9, 17, 33) ; however, these results contrast with those of Takimoto et al. (39) , who reported a deleterious role of NOS3 in the LV remodeling induced by TAC in WT mice. In the TAC model, several investigators have reported that up to 1 mo of follow-up, WT mice develop moderate hypertrophy without signs of heart failure (16, 17, 32) . In the study by Takimoto et al. (39) , however, WT mice developed rapid and severe LV failure, accompanied by increased cardiac superoxide production (39) . The findings of Takimoto et al. (39) are similar to those found in WT mice fed a HFD, both in the present study and previously (30) , implying that differences in the experimental environment may account for the differences observed between investigators.
Oxidative stress levels are greater in cardiomyocytes isolated from HFD-fed WT mice than in HFD-fed NOS3 Ϫ/Ϫ mice after TAC; oxidative stress levels are markedly decreased by L-NAME, demonstrating the role of NOS in ROS production. Increased oxidative stress has been incriminated in adverse LV remodeling in multiple studies. Mechanisms may include direct effects on cellular apoptosis, hypertrophy, mitochondrial function, and extracellular matrix (40) . Inhibitors of the mitochondrial electron chain transport complex 1 (rotenone) and complex 2 (TTFA) also decreased the level of oxidative stress in cardiomyocytes of HFD-fed WT mice after 7 days of TAC. Neither rotenone nor TTFA inhibited NO production by NOS, as reflected by DAF-2DA fluorescence, suggesting that an effect of these mitochondrial inhibitors on NOS function is unlikely. It is more likely that the inhibition of oxidative stress by rotenone and TTFA reflects the involvement of mitochondria in the increase of cardiomyocyte oxidative stress after HFD and TAC.
Several mechanisms could be responsible for the involvement of mitochondria in the increased oxidative stress detected in the cardiomyocytes of WT mice after HFD feeding and TAC. Mitochondria are considered the major intracellular site of superoxide production, and mitochondrial dysfunction from any cause can increase oxidative stress (4, 38) . It is, however, unlikely that this mechanism plays an important role in our study, since no difference in ROS production was detected between the mitochondria of WT and NOS3 Ϫ/Ϫ mice after HFD and TAC. It is noteworthy that we did find that mitochondrial respiration and ATP production were decreased in NOS3 Ϫ/Ϫ mice, particularly when mitochondria were exposed to a fatty acid environment. This finding may be explained by an impaired ␤-oxidation in the mitochondria of NOS3 Ϫ/Ϫ mice (22) . Mitochondria are the major site of ATP production. The mitochondria of NOS3 Ϫ/Ϫ mice produced lower amounts of ATP than the mitochondria of WT mice, both at baseline and after HFD and TAC. It has recently been reported that ATP stimulates NOS3 activity through a PI3K-AKT pathway and increases phosphorylation of NOS3 at Ser 1177 (36) . In turn, the Ser 1177 phosphorylated NOS3 may produce more ROS in an oxidative stress environment (5). Thus mitochondria may be able to increase the oxidative stress levels in NOS3-expressing WT mice through their production of ATP, by increasing ROS production by NOS3. This possibility is supported by the finding that Ser 1177 -NOS3 is increased in HFD-fed WT mice after TAC compared with SD-fed control mice, suggesting that the PI3K-AKT pathway is activated. Of note, we have only shown an increase in the production of ATP rather than an increase in the tissue ATP content, which could also be regulating the phosphorylation of NOS3. An additional direct role of increased reactive nitrosative species in the development of adverse LV remodeling and failure cannot be eliminated. No difference in the myocardial gene expression of other oxidative enzymes between the WT and NOS3 Ϫ/Ϫ mice at baseline and after HFD-feeding and TAC was noted.
We considered the procedure of feeding a HFD and inducing TAC as one intervention and did not investigate WT or NOS3 Ϫ/Ϫ mice fed a SD after TAC; these groups may provide additional insights on the mechanisms by which IR and pressure-overload interact. Moreover, a limitation of the study is that no sham-operated groups were included.
In summary, the role of NOS3 in ventricular remodeling and failure induced by pressure-overload depends on the systemic environment. The presence of NOS3 increases oxidative stress and exacerbates adverse ventricular remodeling in conditions of feeding a HFD and IR. The deleterious effects of NOS3 in HFD and TAC may involve interactions between NOS3 and mitochondria.
